Michael B. Hoffman, Director, 10% Owner at Onconova Therapeutics, Inc. (ONTX), bought 57,295 shares at $11.96 ($683K) on 2014-01-24, disclosed to the SEC on 2014-01-27.
Scheduled purchase ($683k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.96 | 31,706 | $379K | 55.5% |
| 2 | $11.86 | 25,589 | $303K | 44.5% |
| Total | $11.92 avg | 57,295 | $683K | 100% |
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |